MyBestPharm has been acquired by Urgo Group
Warsaw – CFI is pleased to announce it acted as exclusive financial advisor to MyBestPharm S.A. in its acquisition by Urgo Sp. z o. o.
MyBestPharm S.A., a prominent digitally native vertical brand in Poland, specializes in high-quality dietary supplements and functional foods. Since beginning operations in 2021, the Company’s commitment to excellence has led to double-digit growth each year and a continuously expanding product portfolio within just four years.
Urgo Group, a French family-owned company, is a leading global specialist in wound care, consumer health, and the treatment of complex conditions. This move strengthens their presence in Poland, enhancing their role in medical (wound treatment) and consumer healthcare products.
This transaction closed on 15 April 2025.
Healthcare & Life Sciences
has been acquired by
Transaction details
Polish dietary supplement company MyBestPharm has been acquired by the French Urgo Group
This transaction was advised by:
Our latest transactions
Healthcare & Life Sciences
has sold a minority stake to
Transaction details
Turin-based radiological company Chiron Group has sold a minority stake to KYIP Capital, accelerating the Group’s expansion
Real Estate & Construction
has been acquired by
Transaction details
BridgeFab, a leading structural steel and metalwork companies in Southeast Queensland, has been acquired by McNab
Software & IT Services
have sold
to
a portfolio company of
Transaction details
Cevinio, a European software company specialising in AI-driven automation for Accounts Payable and Accounts Receivable processes, has been sold to Serrala, a global provider of finance process automation software, supporting end-to-end financial operations through a modular, cloud-ready platform
